| P50 | author | Peter J Weiden | Q89238215 |
| | Gbenga Ogedegbe | Q64497848 |
| P2093 | author name string | Martha Sajatovic | |
| | Dawn I. Velligan | |
| | Marcia A. Valenstein | |
| P2860 | cites work | Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophrenia | Q24674950 |
| | Determinants of medication compliance in schizophrenia: empirical and clinical findings | Q28254303 |
| | Adherence to Medication | Q28314923 |
| | Using drug claims data to assess the relationship of medication adherence with hospitalization and costs | Q30652843 |
| | Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission | Q30714937 |
| | Nature and operation of attitudes | Q34124588 |
| | Treatment non-adherence in affective disorders. | Q34592227 |
| | Neuroleptic dysphoria: towards a new synthesis | Q35597237 |
| | Overview of partial compliance. | Q35609641 |
| | The concordance of self-report with other measures of medication adherence: a summary of the literature | Q35814893 |
| | Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia | Q35855167 |
| | Identifying and improving non-adherence in bipolar disorders. | Q36286408 |
| | Adherence to antiretroviral therapy assessed by unannounced pill counts conducted by telephone | Q36416650 |
| | Defining and assessing adherence to oral antipsychotics: a review of the literature | Q36481418 |
| | Three-year outcomes for maintenance therapies in recurrent depression | Q68610334 |
| | The rational clinical examination. Is this patient taking the treatment as prescribed? | Q70712925 |
| | A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity | Q72551910 |
| | Subjective response to neuroleptics in schizophrenia | Q72657709 |
| | A comparative study of insight scales and their relationship to psychopathological and clinical variables | Q74509398 |
| | Compliance with antidepressants in a primary care setting, 1: Beyond lack of efficacy and adverse events | Q74617402 |
| | Predictors of a medical-offset effect among patients receiving antidepressant therapy | Q74626970 |
| | The use of electronic monitoring (MEMS) to evaluate antipsychotic compliance in outpatients with schizophrenia | Q79509524 |
| | Relationships among subjective and objective measures of adherence to oral antipsychotic medications | Q80981074 |
| | Development of the ASK-20 adherence barrier survey | Q94701818 |
| | Further testing of the reliability and validity of the ASK-20 adherence barrier questionnaire in a medical center outpatient population | Q95374735 |
| | Self-report adherence measures in chronic illness: retest reliability and predictive validity | Q95811534 |
| | The longitudinal course of recurrent affective illness: life chart data from research patients at the NIMH. | Q36486868 |
| | Antipsychotic adherence over time among patients receiving treatment for schizophrenia: a retrospective review. | Q36654304 |
| | A review of brief medication-adherence instruments used in patients with schizophrenia and bipolar disorder | Q36965871 |
| | The use of individually tailored environmental supports to improve medication adherence and outcomes in schizophrenia | Q37076300 |
| | Long-term treatment of depression | Q37334208 |
| | A large-scale validation study of the Medication Adherence Rating Scale (MARS). | Q38478463 |
| | Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses | Q38499772 |
| | Concurrent and predictive validity of a self-reported measure of medication adherence | Q39512844 |
| | Time series analysis of treatment adherence patterns in individuals with obstructive sleep apnea. | Q40055390 |
| | Twelve-month outcome of adolescents with bipolar disorder following first hospitalization for a manic or mixed episode | Q40227625 |
| | Self-reported adherence to treatment with mood stabilizers, plasma levels, and psychiatric hospitalization | Q40623890 |
| | Compliance during treatment with antidepressants | Q41452191 |
| | Adherence to treatment regimen in depressed patients treated with amitriptyline or fluoxetine. | Q43711796 |
| | Nonadherence with mood stabilizers: prevalence and predictors | Q43999454 |
| | Brief evaluation of medication influences and beliefs: development and testing of a brief scale for medication adherence | Q44116697 |
| | Evaluation of noncompliance in schizophrenia patients using electronic monitoring (MEMS) and its relationship to sociodemographic, clinical and psychopathological variables | Q44193921 |
| | Predicting engagement with services for psychosis: insight, symptoms and recovery style | Q44299948 |
| | Subjective response as a predictor of outcome in pharmacotherapy: the consumer has a point | Q44403262 |
| | The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development | Q44543027 |
| | Risperidone plasma levels, clinical response and side-effects | Q45163701 |
| | Treatment adherence and illness insight in veterans with bipolar disorder | Q45332060 |
| | Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia | Q46630440 |
| | Effect of subjective reasoning and neurocognition on medication adherence for persons with schizophrenia | Q48437788 |
| | Lithium Maintenance: 1. A Standard Education Programme for Patients | Q48520352 |
| | Moderating role of attitudinal ambivalence within the theory of planned behaviour | Q48597527 |
| | Electronic monitoring of antipsychotic medication adherence in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of its reliability and predictive validity. | Q51898329 |
| | The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression. | Q51988686 |
| | Limits of confidence in tracer compounds as a means of measuring patient compliance with medication. | Q52134674 |
| | Beliefs about antidepressant medications in primary care patients: relationship to self-reported adherence. | Q52288482 |
| | Rating of medication influences (ROMI) scale in schizophrenia. | Q52881115 |
| | A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia. | Q52974125 |
| | Adherence therapy for people with schizophrenia. European multicentre randomised controlled trial. | Q53215686 |
| | Reappraising insight in psychosis | Q60460793 |
| | The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder | Q61480061 |
| | Neuroleptic dysphoria | Q68296220 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adherence (medicine) | Q67004728 |
| P304 | page(s) | 591-599 | |
| P577 | publication date | 2009-07-25 | |
| P1433 | published in | Journal of Psychosomatic Research | Q15709516 |
| P1476 | title | Measurement of psychiatric treatment adherence | |
| P478 | volume | 69 | |